Literature DB >> 28579063

Choroidal Changes Associated With Subretinal Drusenoid Deposits in Age-related Macular Degeneration Using Swept-source Optical Coherence Tomography.

Inês Laíns1, Jay Wang2, Joana Providência3, Steven Mach2, Pedro Gil4, João Gil4, Marco Marques3, Grayson Armstrong2, Shady Garas2, Patrícia Barreto5, Ivana K Kim2, Demetrios G Vavvas2, Joan W Miller2, Deeba Husain2, Rufino Silva4, John B Miller6.   

Abstract

PURPOSE: To compare choroidal vascular features of eyes with and without subretinal drusenoid deposits (SDD), using swept-source optical coherence tomography (SS OCT).
DESIGN: Multicenter, cross-sectional study.
METHODS: We prospectively recruited patients with intermediate age-related macular degeneration (AMD), without other vitreoretinal pathology. All participants underwent complete ophthalmic examination, color fundus photography (used for AMD staging), and spectral-domain OCT (to evaluate the presence of SDD). SS OCT was used to obtain automatic macular choroidal thickness (CT) maps, according to the Early Treatment Diabetic Retinopathy Study (ETDRS) sectors. For data analysis, we considered mean choroidal thickness as the arithmetic mean value of the 9 ETDRS sectors. SS OCT en face images of choroidal vasculature were also captured and converted to binary images. Choroidal vascular density (CVD) was calculated as a percent area occupied by choroidal vessels in a 6-mm-diameter submacular circular. Choroidal vessel volume was calculated by multiplying the average CVD by macular area and CT. Multilevel mixed linear models (to account for the inclusion of 2 eyes of same subject) were performed for analysis.
RESULTS: We included 186 eyes (n = 118 subjects), 94 (50.5%) presenting SDD. Multiple regression analysis revealed that, controlling for age, eyes with SDD presented a statistically thinner mean CT (ß = -21.9, P = .006) and CT in all the individual ETDRS fields (ß ≤ -18.79, P ≤ .026). Mean choroidal vessel volume was also significantly reduced in eyes with SDD (ß = -0.003, P = .007). No significant associations were observed with mean CVD.
CONCLUSION: In subjects with intermediate AMD, choroidal thickness and vessel volume are reduced in the presence of subretinal drusenoid deposits.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2017        PMID: 28579063     DOI: 10.1016/j.ajo.2017.05.021

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  9 in total

1.  OCT Angiography and Cone Photoreceptor Imaging in Geographic Atrophy.

Authors:  Jia Qin; Nicholas Rinella; Qinqin Zhang; Hao Zhou; Jessica Wong; Michael Deiner; Austin Roorda; Travis C Porco; Ruikang K Wang; Daniel M Schwartz; Jacque L Duncan
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-12-03       Impact factor: 4.799

2.  Biomarkers for Nonexudative Age-Related Macular Degeneration and Relevance for Clinical Trials: A Systematic Review.

Authors:  Vivienne Fang; Maria Gomez-Caraballo; Eleonora M Lad
Journal:  Mol Diagn Ther       Date:  2021-08-25       Impact factor: 4.074

3.  Subretinal drusenoid deposits as a biomarker of age-related macular degeneration progression via reduction of the choroidal vascularity index.

Authors:  Solmaz Abdolrahimzadeh; Mariachiara Di Pippo; Edoardo Sordi; Mattia Cusato; Andrew John Lotery
Journal:  Eye (Lond)       Date:  2022-06-23       Impact factor: 3.775

4.  Subtype-differentiated impacts of subretinal drusenoid deposits on photoreceptors revealed by adaptive optics scanning laser ophthalmoscopy.

Authors:  Xiaoyu Xu; Xiaolin Wang; SriniVas R Sadda; Yuhua Zhang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2020-06-02       Impact factor: 3.117

5.  Computational modeling of retinal hypoxia and photoreceptor degeneration in patients with age-related macular degeneration.

Authors:  Kevin J McHugh; Dian Li; Jay C Wang; Leon Kwark; Jessica Loo; Venkata Macha; Sina Farsiu; Leo A Kim; Magali Saint-Geniez
Journal:  PLoS One       Date:  2019-06-11       Impact factor: 3.240

6.  Effects of Macuprev® Supplementation in Age-Related Macular Degeneration: A Double-Blind Randomized Morpho-Functional Study Along 6 Months of Follow-Up.

Authors:  Mariacristina Parravano; Massimiliano Tedeschi; Daniela Manca; Eliana Costanzo; Antonio Di Renzo; Paola Giorno; Lucilla Barbano; Lucia Ziccardi; Monica Varano; Vincenzo Parisi
Journal:  Adv Ther       Date:  2019-06-25       Impact factor: 3.845

Review 7.  Choroidal Vasculature Changes in Age-Related Macular Degeneration: From a Molecular to a Clinical Perspective.

Authors:  Serena Fragiotta; Luca Scuderi; Clemente Maria Iodice; Daria Rullo; Mariachiara Di Pippo; Elisa Maugliani; Solmaz Abdolrahimzadeh
Journal:  Int J Mol Sci       Date:  2022-10-09       Impact factor: 6.208

8.  CHOROIDAL THICKNESS AND VASCULARITY VARY WITH DISEASE SEVERITY AND SUBRETINAL DRUSENOID DEPOSIT PRESENCE IN NONADVANCED AGE-RELATED MACULAR DEGENERATION.

Authors:  Tiarnan D Keenan; Brandon Klein; Elvira Agrón; Emily Y Chew; Catherine A Cukras; Wai T Wong
Journal:  Retina       Date:  2020-04       Impact factor: 3.975

9.  Visualization of Choriocapillaris and Choroidal Vasculature in Healthy Eyes With En Face Swept-Source Optical Coherence Tomography Versus Angiography.

Authors:  Jay C Wang; Inês Laíns; Rebecca F Silverman; Lucia Sobrin; Demetrios G Vavvas; Joan W Miller; John B Miller
Journal:  Transl Vis Sci Technol       Date:  2018-12-20       Impact factor: 3.283

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.